276 related articles for article (PubMed ID: 34883577)
1. Evaluation and Characterization of Curcumin-β-Cyclodextrin and Cyclodextrin-Based Nanosponge Inclusion Complexation.
Mashaqbeh H; Obaidat R; Al-Shar'i N
Polymers (Basel); 2021 Nov; 13(23):. PubMed ID: 34883577
[TBL] [Abstract][Full Text] [Related]
2. Weak complexation of 5-fluorouracil with β-cyclodextrin, carbonate, and dianhydride crosslinked β-cyclodextrin:
Mashaqbeh H; Obaidat R; Al-Shar'i NA; El-Elimat T; Alnabulsi S
Res Pharm Sci; 2022 Aug; 17(4):334-349. PubMed ID: 36034082
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of EDTA Dianhydride Versus Diphenyl Carbonate Nanosponges for Curcumin.
Mashaqbeh H; Obaidat R; Al-Shar'i NA
AAPS PharmSciTech; 2022 Aug; 23(7):229. PubMed ID: 35974237
[TBL] [Abstract][Full Text] [Related]
4. Solubility and dissolution rate enhancement of ibuprofen by cyclodextrin based carbonate nanosponges.
Shoaib QU; Latif S; Ijaz QA; Afzal H; Siddique MI; Hussain A; Arshad MS; Bukhari NI; Abbas N
Pak J Pharm Sci; 2021 May; 34(3(Supplementary)):1045-1055. PubMed ID: 34602431
[TBL] [Abstract][Full Text] [Related]
5. Enhancement in the therapeutic potential of lapatinib ditosylate against breast cancer by the use of β-cyclodextrin based ternary nanosponge system.
Tanaji Mane P; Sopanrao Wakure B; Shridhar Wakte P
Int J Pharm; 2023 Jul; 642():123210. PubMed ID: 37433350
[TBL] [Abstract][Full Text] [Related]
6. Formulation and evaluation of Piroxicam nanosponge for improved internal solubility and analgesic activity.
Gaber DA; Radwan MA; Alzughaibi DA; Alail JA; Aljumah RS; Aloqla RM; Alkhalifah SA; Abdoun SA
Drug Deliv; 2023 Dec; 30(1):2174208. PubMed ID: 36744372
[TBL] [Abstract][Full Text] [Related]
7. Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.
Hayiyana Z; Choonara YE; Makgotloe A; du Toit LC; Kumar P; Pillay V
Curr Pharm Des; 2016; 22(46):6988-6997. PubMed ID: 27981908
[TBL] [Abstract][Full Text] [Related]
8. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of Bioavailability of Non-nucleoside Reverse Transciptase Inhibitor Using Nanosponges.
Rao MRP; Shirsath C
AAPS PharmSciTech; 2017 Jul; 18(5):1728-1738. PubMed ID: 27757921
[TBL] [Abstract][Full Text] [Related]
10. Design and formulation of polymeric nanosponge tablets with enhanced solubility for combination therapy.
Moin A; Roohi NKF; Rizvi SMD; Ashraf SA; Siddiqui AJ; Patel M; Ahmed SM; Gowda DV; Adnan M
RSC Adv; 2020 Sep; 10(57):34869-34884. PubMed ID: 35514416
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of solubility enhancement, antioxidant activity, and cytotoxicity studies of kynurenic acid loaded cyclodextrin nanosponge.
Dhakar NK; Caldera F; Bessone F; Cecone C; Pedrazzo AR; Cavalli R; Dianzani C; Trotta F
Carbohydr Polym; 2019 Nov; 224():115168. PubMed ID: 31472867
[TBL] [Abstract][Full Text] [Related]
12. CDI cross-linked β-cyclodextrin nanosponges of paliperidone: synthesis and physicochemical characterization.
Sherje AP; Surve A; Shende P
J Mater Sci Mater Med; 2019 Jun; 30(6):74. PubMed ID: 31197491
[TBL] [Abstract][Full Text] [Related]
13. Potential of erlotinib cyclodextrin nanosponge complex to enhance solubility, dissolution rate, in vitro cytotoxicity and oral bioavailability.
Dora CP; Trotta F; Kushwah V; Devasari N; Singh C; Suresh S; Jain S
Carbohydr Polym; 2016 Feb; 137():339-349. PubMed ID: 26686138
[TBL] [Abstract][Full Text] [Related]
14. Investigation of Cyclodextrin-Based Nanosponges for Solubility and Bioavailability Enhancement of Rilpivirine.
Rao MRP; Chaudhari J; Trotta F; Caldera F
AAPS PharmSciTech; 2018 Jul; 19(5):2358-2369. PubMed ID: 29869305
[TBL] [Abstract][Full Text] [Related]
15. Comparative Evaluation of Solubility, Cytotoxicity and Photostability Studies of Resveratrol and Oxyresveratrol Loaded Nanosponges.
Dhakar NK; Matencio A; Caldera F; Argenziano M; Cavalli R; Dianzani C; Zanetti M; López-Nicolás JM; Trotta F
Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31635183
[TBL] [Abstract][Full Text] [Related]
16. Pyromellitic dianhydride crosslinked cyclodextrin nanosponges for curcumin controlled release; formulation, physicochemical characterization and cytotoxicity investigations.
Rafati N; Zarrabi A; Caldera F; Trotta F; Ghias N
J Microencapsul; 2019 Dec; 36(8):715-727. PubMed ID: 31530203
[No Abstract] [Full Text] [Related]
17. Preparation and investigation of a novel combination of
Shah HS; Zaib S; Khan I; Sliem MA; Alharbi O; Al-Ghorbani M; Jawad Z; Shahzadi K; Awan S
Front Pharmacol; 2023; 14():1325498. PubMed ID: 38125886
[No Abstract] [Full Text] [Related]
18. Encapsulation of Babchi Oil in Cyclodextrin-Based Nanosponges: Physicochemical Characterization, Photodegradation, and In Vitro Cytotoxicity Studies.
Kumar S; ; Trotta F; Rao R
Pharmaceutics; 2018 Sep; 10(4):. PubMed ID: 30261580
[TBL] [Abstract][Full Text] [Related]
19. Cyclodextrin-based nanosponges: A critical review.
Sherje AP; Dravyakar BR; Kadam D; Jadhav M
Carbohydr Polym; 2017 Oct; 173():37-49. PubMed ID: 28732878
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Enhanced Skin Permeation and Retention of Imiquimod Loaded in β-Cyclodextrin Nanosponge Hydrogel.
Argenziano M; Haimhoffer A; Bastiancich C; Jicsinszky L; Caldera F; Trotta F; Scutera S; Alotto D; Fumagalli M; Musso T; Castagnoli C; Cavalli R
Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30897794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
